Gottlieb, A. B., A. W. Armstrong, J. F. Merola, A. . Napoli, M. Nowak, S. Banerjee, T. Lehman, and P. J. Mease. “Impact of Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, Deucravacitinib, on Psoriasis in Patients With Active Psoriatic Arthritis: Results from a Phase 2 Trial”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 2, Mar. 2024, p. s383, doi:10.25251/skin.8.supp.383.